Long-acting reversible contraceptive (LARCs) methods
- PMID: 32014434
- DOI: 10.1016/j.bpobgyn.2019.12.002
Long-acting reversible contraceptive (LARCs) methods
Abstract
Unplanned pregnancy (UP) is a public health problem, which affects millions of women worldwide. Providing long-acting reversible contraceptive (LARC) methods is an excellent strategy to avoid or at least reduce UP, because the effectiveness of these methods is higher than other methods, and is indeed comparable to that of permanent contraception. As the initial introduction of the inert plastic intrauterine device (IUD) and of the six-rod implant, pharmaceutical companies have introduced a copper IUD (Cu-IUD), different models of levonorgestrel-releasing intrauterine system (LNG IUS), and one and two-rod implants, which certainly improved women's LARC options. The main characteristic of LARCs is that they provide high contraceptive effectiveness with a single intervention, and that they can be used for a long time. Emerging evidence from the last few years has demonstrated that it is possible to extend the use of the 52 mg LNG IUS and of the etonogestrel-implant beyond five- and three years, respectively, which adds new value to these LARCs.
Keywords: Contraception; Copper intrauterine device; LARCs; Levonorgestrel-releasing intrauterine system; Long acting contraceptives; Subdermal implants.
Copyright © 2019. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest LB and IM have received honoraria as members of advisory boards and have been invited as speakers at scientific meetings for Bayer Healthcare Pharmaceuticals and Merck. None of the other authors have any conflicts of interest to declare.
Similar articles
-
Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.Hum Reprod. 2014 Oct 10;29(10):2163-70. doi: 10.1093/humrep/deu191. Epub 2014 Aug 1. Hum Reprod. 2014. PMID: 25085802
-
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain.Eur J Contracept Reprod Health Care. 2024 Oct;29(5):224-232. doi: 10.1080/13625187.2024.2369843. Epub 2024 Jul 11. Eur J Contracept Reprod Health Care. 2024. PMID: 38989683
-
A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.Hum Reprod. 2014 Jul;29(7):1393-9. doi: 10.1093/humrep/deu089. Epub 2014 May 8. Hum Reprod. 2014. PMID: 24812309 Clinical Trial.
-
Long-acting reversible contraception: a review in special populations.Pharmacotherapy. 2014 Jan;34(1):46-59. doi: 10.1002/phar.1358. Epub 2013 Oct 15. Pharmacotherapy. 2014. PMID: 24130075 Review.
-
Extended duration of use of long-acting reversible contraceptives: Systematic review.Can Fam Physician. 2025 Feb;71(2):e35-e52. doi: 10.46747/cfp.7102e35. Can Fam Physician. 2025. PMID: 39965971 Free PMC article.
Cited by
-
Changes in Canadian contraceptive choices: results of a national survey on hormonal contraceptive use.BMC Womens Health. 2025 Mar 29;25(1):147. doi: 10.1186/s12905-025-03597-3. BMC Womens Health. 2025. PMID: 40155885 Free PMC article.
-
Discontinuation of long-acting reversible contraceptive methods and associated factors among reproductive-age women in Shashemene town, Oromia, Ethiopia.Front Glob Womens Health. 2024 May 7;5:1269302. doi: 10.3389/fgwh.2024.1269302. eCollection 2024. Front Glob Womens Health. 2024. PMID: 38774251 Free PMC article.
-
Levonorgestrel intrauterine device with absence of threads: don't take expulsion for granted! A case series of possible errors in ultrasound evaluation, in case of "lost IUDs".J Ultrasound. 2025 Mar;28(1):203-207. doi: 10.1007/s40477-023-00807-2. Epub 2023 Jul 29. J Ultrasound. 2025. PMID: 37516719
-
Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study.BMC Womens Health. 2025 May 24;25(1):252. doi: 10.1186/s12905-025-03794-0. BMC Womens Health. 2025. PMID: 40413445 Free PMC article.
-
Clinician and policymaker perspectives on the barriers and enablers to implementing and scaling up integrated postpartum intrauterine contraceptive services within maternity care in Nepal: a qualitative study.Lancet Reg Health Southeast Asia. 2025 May 14;37:100599. doi: 10.1016/j.lansea.2025.100599. eCollection 2025 Jun. Lancet Reg Health Southeast Asia. 2025. PMID: 40487913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials